Neuromodulation Market 2019 Global Key Country Analysis: BioAlps Association, Bioness Inc., Soterix Medical, Medtronic, Abbott, Boston Scientific, LivaNova, Cochlear, MED-EL, Nevro, NeuroPace, National Democratic Institute (NDI), BioControl Medical

The neuromodulation market accounted to USD 4.05billion in 2016 growing at a CAGR of 12.22% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Get Exclusive Sample Report at: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-neuromodulation-market

Global Neuromodulation Market by Technology (Internal Neuromodulation, External Neuromodulation), By Application (SCS, DBS, Sacral, Vagus, Gastric Electrical, Transcutaneous Electrical, Repetitive Transcranial Magnetic, Respiratory Electrical), By Geography – Industry Trends and Forecast to 2024.

Neuromodulation is technology which is used for modification or variation in the nerve activity by using chemical agents or electrical stimulation to the specific neurological sites in the body. Neuromodulation devices are used by the application of electrodes to the brain, peripheral nerves or the spinal cord. The therapy provides relief to patients from pain and accompanying side-effects of drugs. The technology used is expected to replace conventional treatments for neurological disorders.

Major market drivers and restraints:

• Rise in geriatric population
• Increase in cases of neurological diseases such as Alzheimer’s and Parkinson’s diseases
• Increase in awareness regarding the safety and efficacy of neurostimulator devices
• Robust product pipeline
• Rise in investments and funds
• Unfavorable reimbursement policies
• Lack of healthcare professionals

Table of Contents:

1. Introduction

2. Market Segmentation

3. Market Overview

4. Executive Summary

5. Premium Insights

6. Global, By Component
And More...

Request for Detailed TOC: https://databridgemarketresearch.com/toc/?dbmr=global-neuromodulation-market

Major Market Competitors:

• BioAlps Association
• Bioness Inc.
• Soterix Medical Inc.
• Medtronic
• Abbott
• Boston Scientific Corporation
• LivaNova PLC
• Axonics Modulation Technologies, Inc.
• Cochlear Ltd.
• MED-EL
• Nevro Corp.
• Neuronetics
• Cogentix Medical
• Johnson & Johnson Services Inc.
• NeuroPace, Inc.
• NeuroSigma, Inc.
• NDI
• IntraPace, Inc.
• DynaMD
• BioControl Medical
• Synapse Biomedical Inc.
• Functional Neuromodulation, Ltd.
• Stimwave LLC
• Biegler GmbH
• Stimwave LLC
• Modulus, Inc.
• EnteroMedics Inc.
• Integer Holdings Corporation

Market Segmentation:

The neuromodulation market is segmented by technology into internal neuromodulation and external neuromodulation (Non-invasive). Internal Neuromodulation is sub segmented into spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS) and gastric electrical stimulation (GES).External neuromodulation (non-invasive) is sub segmented into transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS) and respiratory electrical stimulation (RES).

• On the basis of application the market is segmented into spinal cord stimulation (SCS), deep brain stimulation (DBS), sacral nerve stimulation market, vagus nerve stimulation market, gastric electrical stimulation market, transcutaneous electrical nerve stimulation market, repetitive transcranial magnetic stimulation market and respiratory electrical stimulation market.

• Spinal cord stimulation (SCS) market is further sub segmented by application into failed back syndrome (FBSS), chronic pain and ischemia. Deep brain stimulation (DBS) marketis further sub segmented by application into Parkinson’s disease, tremor and depression. Sacral Nerve Stimulation Marketis further sub segmented by application into urine incontinence and fecal incontinence.Vagus Nerve Stimulation Marketis further sub segmented by application intoepilepsy and others.Gastric electrical stimulation market is further sub segmented by application intogastroparesis and obesity.Transcutaneous electrical nerve stimulation market is further sub segmented by application into treatment resistant depression and others. Repetitive transcranial magnetic stimulation market is further sub segmented by application into depression and migraine headache.Respiratory electrical stimulation market is further sub segmented by application into spinal cord injury.

• On the basis of geography, neuromodulation market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, andBrazil among others. In 2017, North America is expected to dominate the market.

The neuromodulation market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of neuromodulation market for global, Europe, North America, Asia Pacific and South America.

To Get More Information about this Market: https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-neuromodulation-market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com

This release was published on openPR.